<--- Back to Details
First PageDocument Content
Ofatumumab / B-cell chronic lymphocytic leukemia / Lymphoma / Rituximab / CD20 / Alemtuzumab / Fludarabine / Bendamustine / Ocrelizumab / Medicine / Oncology / Monoclonal antibodies
Ofatumumab
B-cell chronic lymphocytic leukemia
Lymphoma
Rituximab
CD20
Alemtuzumab
Fludarabine
Bendamustine
Ocrelizumab
Medicine
Oncology
Monoclonal antibodies

Microsoft Word - urm-January_26_2011-OFA_2011_r~CN_NK.doc

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Download Document from Source Website

File Size: 828,59 KB

Share Document on Facebook

Similar Documents

CD34 / K562 cells / CD20 / Hep G2 / HCF

Networks - Supplemental Table 2

DocID: 1oB7J - View Document

Communiqué Orphan anti-CD20 - GB

DocID: 1di66 - View Document

Paragraph / Comparative Toxicogenomics Database / Ofatumumab / CD20 / Biology / Workflow / Science / Business / Typography / Writing / Workflow technology

Text mining workflow for extraction of paragraphs from full articles describing drug-gene interactions to support Onco KEM software platform for personalized treatments Fanny Perraudeau, David Morley, Mohammad Afshar, Ma

DocID: 1aeJg - View Document

HuMax / CD20 / Winkel / Pharmacology / Biology / Pharmaceutical industry / Genmab / Ofatumumab / Monoclonal antibodies

Q&A GENMAB 4TH OF MARCH 2015 WITH JAN VAN DE WINKEL Q&A GENMAB 4TH OF MARCH 2015

DocID: 16oNF - View Document

Leukemia / Minimal residual disease / Lymphocytic leukemia / Acute leukemia / Acute lymphoblastic leukemia / Risk / Philadelphia chromosome / Chromosomal translocation / CD20 / Genetics / Biology / Cytogenetics

Microsoft PowerPoint - 4 Borowitz MRD.pptx

DocID: 12gRI - View Document